v3.25.4
Consolidated Statements of Changes in Common Shareholders' Equity - USD ($)
$ in Millions
Total
Common shares
Treasury shares
Paid-in- surplus
Retained earnings
AOCI
[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)     (500,200,000)      
Beginning balance (in shares) at Dec. 31, 2022   1,112,600,000        
Beginning balance at Dec. 31, 2022 $ 12,163 $ 2,782 $ (54,004) $ 5,080 $ 58,887 $ (582)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 6,379       6,379  
Other comprehensive income/(loss) (32) [2]         (32)
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares)   300,000 500,000      
Conversion, stock option exercises, forfeitures, ESPP, and other 163   $ 50 113    
Share repurchase programs (Note 18) (in shares)     (3,500,000)      
Share repurchase programs (Note 18) (712)   $ (712)      
Cash dividends declared (3,173)       (3,173)  
Ending balance (in shares) at Dec. 31, 2023   1,112,900,000        
Ending balance (in shares) at Dec. 31, 2023     (503,200,000)      
Ending balance at Dec. 31, 2023 14,788 $ 2,782 $ (54,666) 5,193 62,093 (614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)     (503,200,000)      
Net income 6,747       6,747  
Other comprehensive income/(loss) (109) [2]         (109)
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares)   100,000 700,000      
Conversion, stock option exercises, forfeitures, ESPP, and other $ 191 $ 1 $ 49 141    
Share repurchase programs (Note 18) (in shares) (6,303,166)   (6,300,000)      
Share repurchase programs (Note 18) $ (1,515)   $ (1,515)      
Cash dividends declared $ (3,212)       (3,212)  
Ending balance (in shares) at Dec. 31, 2024 604,241,260 1,113,000,000        
Ending balance (in shares) at Dec. 31, 2024     (508,800,000)      
Ending balance at Dec. 31, 2024 $ 16,890 $ 2,783 $ (56,132) 5,334 65,628 (723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)     (508,800,000)      
Net income 7,138       7,138  
Other comprehensive income/(loss) 132 [2]         132
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares)   200,000 800,000      
Conversion, stock option exercises, forfeitures, ESPP, and other $ 238   $ 66 172    
Share repurchase programs (Note 18) (in shares) (11,857,159)   (11,900,000)      
Share repurchase programs (Note 18) $ (2,694)   $ (2,777) 83    
Cash dividends declared $ (3,237)       (3,237)  
Ending balance (in shares) at Dec. 31, 2025 593,245,884 1,113,200,000        
Ending balance (in shares) at Dec. 31, 2025     (519,900,000)      
Ending balance at Dec. 31, 2025 $ 18,467 $ 2,783 $ (58,843) $ 5,589 $ 69,529 $ (591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)     (519,900,000)      
[1] AOCI = Accumulated Other Comprehensive Income/Loss (Note 9)
[2] Net of deferred taxes of ($24) million, $6 million, and $31 million during 2025, 2024, and 2023, respectively.